Clik here to view.
Propanc Biopharma Provides Upcoming Milestones
MELBOURNE, Australia Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
Humanigen Reports Positive Phase 3 Topline Results Demonstrating That...
BURLINGAME, Calif. Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with...
View ArticleClik here to view.
Personalis Announces Collaboration with MapKure to Use Personalis’ NeXT...
MENLO PARK, Calif. Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced a collaboration with MapKure, LLC, a clinical-stage company focusing on genetically...
View ArticleClik here to view.
ARPA Computation Platform Q1 Update: Better Performance, Usability, and Next...
SINGAPORE ARPA, a blockchain-based privacy-preserving computation network, released its Quarter One Update on March 24th, 2021. Over the past years and during the first quarter of 2021, ARPA...
View ArticleClik here to view.
Milestone Study Shows Natural Molecule, Urolithin A, Can Improve Muscle...
LAUSANNE, Switzerland Progression of Duchenne Muscle Dystrophy (DMD) can be delayed in mice by supplementing their diets with Urolithin A, according to new results reported today. The findings,...
View ArticleClik here to view.
金橡医学选择Twist Bioscience为新一代精准医学检验提供动力
美国加州南旧金山和中国北京 专注于实体肿瘤和血液肿瘤检测和分析的精准医疗机构金橡医学今日宣布，他们将把Twist Bioscience新一代测序(NGS)靶向富集和文库制备组合纳入金橡医学的检测组合中，旨在为患者提供更深入的遗传易感性分析和治疗方案，提供更有针对性的治疗方法。 “通过与Twist...
View ArticleClik here to view.
AcornMed Selects Twist Bioscience Technology to Power Next Generation...
SOUTH SAN FRANCISCO, Calif & BEIJING AcornMed Biotechnology Co., Ltd. (AcornMed), a precision medicine organization that specializes in the testing and analysis of solid and blood tumors,...
View ArticleClik here to view.
Clik here to view.
里程碑研究显示，天然分子尿石素A能改善肌营养不良症小鼠的肌肉功能和预期寿命
瑞士洛桑 (美国商业资讯)–今天报道的新结果显示，小鼠饮食中补充尿石素A能延缓其杜氏肌营养不良症(DMD)的进展。上述结果发表于《科学转化医学》(Science Translational Medicine)，有朝一日有望实现为DMD开发新的治疗方案，DMD是一种无法治愈的基因疾病，其特征是进行性肌肉退化。每3,500名新生男孩中约有1例患DMD，通常在儿童期发病，大幅缩短预期寿命。...
View ArticleClik here to view.
Illumina Named One of Singapore’s Best Employers
SINGAPORE Illumina, Inc., today announced, for the second consecutive year, Illumina is honored as one of Singapore’s Best Employers in a survey sponsored by The Straits Times and the marketing firm...
View ArticleClik here to view.
CORRECTING and REPLACING Illumina Named One of Singapore’s Best Employers
SINGAPORE First paragraph, second sentence of release should read: Illumina was second in Health Care and Equipment Services and placed 27th on the overall list. The updated release reads: ILLUMINA...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
ROSALIND, HELiXrUS and Geninus Partner to Bring Powerful New Single Cell...
SAN DIEGO & SEOUL, South Korea ROSALIND®, a software leader in extracting meaningful insights from diverse pools of life science data, today announced that it has partnered with two Seoul-based...
View ArticleClik here to view.
GC Pharma Lights Up to Celebrate ‘World Hemophilia Day’
YONGIN, South Korea GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company, participates in a campaign to celebrate World Hemophilia Day. As part of GC...
View ArticleClik here to view.
Humanigen Reports Positive Data With Lenzilumab in the ZUMA-19 CAR-T Phase 1b...
BURLINGAME, Calif. Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with...
View ArticleClik here to view.
Mirum Pharmaceuticals and CANbridge Pharmaceuticals Enter into Exclusive...
FOSTER CITY, Calif. & BEIJING Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and CANbridge Pharmaceuticals, Inc., announced today that they have entered into a licensing agreement, pursuant to which...
View ArticleClik here to view.
Drug Farm Appoints Dr. Jeysen Yogaratnam as Chief Medical Officer
SHANGHAI & GUILFORD, Conn. Drug Farm, a China- and US-based biotechnology company focused on developing innovative treatments targeting innate immunity for hepatitis B, cancer and autoimmune...
View ArticleClik here to view.
BeiGene Reports First Quarter 2021 Financial Results
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today reported...
View ArticleClik here to view.
Takeda Delivers Resilient FY2020 Results With Strong Margins & Robust...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announced financial results for fiscal year 2020 (period ended March 31, 2021). TAKEDA PRESIDENT AND CHIEF...
View Article